CoChat

Ultrasound-mediated delivery of doxorubicin to the brain results in immune modulation and improved responses to PD-1 blockade in gliomas

Open access
Arrieta, Víctor A., Gould, Andrew, Kim, Kwang-Soo, Habashy, Karl J., Dmello, Crismita, Vázquez-Cervantes, Gustavo I., Palacín-Aliana, Irina, McManus, Graysen, Amidei, Christina, Gomez, Cristal, Dhiantravan, Silpol, Chen, Li, Zhang, Daniel Y., Saganty, Ruth, Cholak, Meghan E., Pandey, Surya, McCord, Matthew, McCortney, Kathleen, Castro, Brandyn, Ward, Rachel, Muzzio, Miguel, Bouchoux, Guillaume, Desseaux, Carole, Canney, Michael, Carpentier, Alexandre, Zhang, Bin, Miska, Jason M., Lesniak, Maciej S., Horbinski, Craig M., Lukas, Rimas V., Stupp, Roger, Lee-Chang, Catalina, Sonabend, Adam M. · 2024 · Nature Communications
Cited by 107

The DOI matches its Crossref record; 19 of the 19 references it cites were found in a registry or an index.

Abstract

Given the marginal penetration of most drugs across the blood-brain barrier, the efficacy of various agents remains limited for glioblastoma (GBM). Here we employ low-intensity pulsed ultrasound (LIPU) and intravenously administered microbubbles (MB) to open the blood-brain barrier and increase the concentration of liposomal doxorubicin and PD-1 blocking antibodies (aPD-1). We report results on a cohort of 4 GBM patients and preclinical models treated with this approach. LIPU/MB increases the concentration of doxorubicin by 2-fold and 3.9-fold in the human and murine brains two days after sonication, respectively. Similarly, LIPU/MB-mediated blood-brain barrier disruption leads to a 6-fold and a 2-fold increase in aPD-1 concentrations in murine brains and peritumoral brain regions from GBM patients treated with pembrolizumab, respectively. Doxorubicin and aPD-1 delivered with LIPU/MB upregulate major histocompatibility complex (MHC) class I and II in tumor cells. Increased brain concentrations of doxorubicin achieved by LIPU/MB elicit IFN-γ and MHC class I expression in microglia and macrophages. Doxorubicin and aPD-1 delivered with LIPU/MB results in the long-term survival of most glioma-bearing mice, which rely on myeloid cells and lymphocytes for their efficacy. Overall, this translational study supports the utility of LIPU/MB to potentiate the antitumoral activities of doxorubicin and aPD-1 for GBM.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s41467-024-48326-w

Cites

19 of 19 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 19 references

Cited by

See all 107

Metadata

Authors
Arrieta, V. A., Gould, A., Kim, K.-S., Habashy, K. J., Dmello, C., Vázquez-Cervantes, G. I., Palacín-Aliana, I., McManus, G., Amidei, C., Gomez, C., Dhiantravan, S., Chen, L., Zhang, D. Y., Saganty, R., Cholak, M. E., Pandey, S., McCord, M., McCortney, K., Castro, B., Ward, R., Muzzio, M., Bouchoux, G., Desseaux, C., Canney, M., Carpentier, A., Zhang, B., Miska, J. M., Lesniak, M. S., Horbinski, C. M., Lukas, R. V., Stupp, R., Lee-Chang, C., & Sonabend, A. M.
Venue
Nature Communications
Published
2024-06-06
Volume
15
Issue
1
Pages
4698-4698
ISSN
2041-1723 (ISSN-L)
OpenAlex
W4399387719
Cited by
107
References
19
FWCI
11.24
Type
journal article
Language
en
Open access
gold

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Ultrasound-mediated delivery of doxorubicin to the brain results in immune modulation and improved responses to PD-1 blockade in gliomas. https://app.cochat.ai/papers/10.1038/s41467-024-48326-w
The paper
Arrieta, V. A., Gould, A., Kim, K.-S., Habashy, K. J., Dmello, C., Vázquez-Cervantes, G. I., Palacín-Aliana, I., McManus, G., Amidei, C., Gomez, C., Dhiantravan, S., Chen, L., Zhang, D. Y., Saganty, R., Cholak, M. E., Pandey, S., McCord, M., McCortney, K., Castro, B., . . . Sonabend, A. M. (2024). Ultrasound-mediated delivery of doxorubicin to the brain results in immune modulation and improved responses to PD-1 blockade in gliomas. Nature Communications. https://doi.org/10.1038/s41467-024-48326-w

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.